ONO-5334, another CTSK inhibitor, was evaluated for its effects in ovariectomized (OVX) cynomolgus monkeys, which exhibit an osteoporosis-like phenotype (Ochi et al. 2014; Yamada et al. 2016). Here, CTSK is linked to osteoporosis.